Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections

被引：8
|
作者：
Watkins, Richard R. [1 ,4 ]
Bonomo, Robert A. [2 ,3 ]
机构：
[1] Northeast Ohio Med Univ, Dept Med, Div Infect Dis, Rootstown, OH USA
[2] VA Northeast Ohio Healthcare Syst, Res Serv, Cleveland, OH USA
[3] Case Western Reserve Univ, Cleveland VA Med Ctr Antimicrobial Resistance & Ep, Cleveland, OH USA
[4] Northeast Ohio Med Univ, Dept Med, 4209 St,OH 44, Rootstown, OH 44272 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2023年 / 76卷
关键词：
antimicrobial resistance; carbapenem-resistant Acinetobacter baumannii; sulbactam-durlobactam; BETA-LACTAM ANTIBIOTICS;
D O I：
10.1093/cid/ciad093
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Antimicrobial resistance in gram-negative pathogens, such as Acinetobacter baumannii, is a serious threat to human health. Sulbactam-durlobactam, a unique beta-lactam and a beta-lactamase inhibitor combination, is a novel agent targeted against carbapenem-resistant A. baumannii. This supplement provides a summary of the development of SUL-DUR, discussing its unique features and role in treating infections caused by CRAB pathogens.
引用
收藏
页码：S163 / S165
页数：3
相关论文
共 50 条
  • [31] Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii
    Bian, Xingchen
    Liu, Xiaofen
    Feng, Meiqing
    Bergen, Phillip J.
    Li, Jian
    Chen, Yuancheng
    Zheng, Huajun
    Song, Sichao
    Zhang, Jing
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (02)
  • [32] Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections
    Song, Joon Young
    Cheong, Hee Jin
    Choi, Won Suk
    Heo, Jung Yeon
    Noh, Ji Yun
    Kim, Woo Joo
    JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 60 (05) : 605 - 611
  • [33] Impact of carbapenem-resistant Acinetobacter baumannii infections on acute pancreatitis patients
    Wu, Di
    Huang, Yilin
    Ding, Junjie
    Jia, Yan
    Liu, Huanmiao
    Xiao, Jie
    Peng, Jie
    PANCREATOLOGY, 2022, 22 (02) : 194 - 199
  • [34] Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections
    Saballs, Mireia
    Pujol, Miquel
    Tubau, Fe
    Pena, Carmen
    Montero, Abelardo
    Dominguez, M. Angeles
    Gudiol, Francesc
    Ariza, Javier
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (03) : 697 - 700
  • [35] Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals?
    Medioli, Filippo
    Bacca, Erica
    Faltoni, Matteo
    Burastero, Giulia Jole
    Volpi, Sara
    Menozzi, Marianna
    Orlando, Gabriella
    Bedini, Andrea
    Franceschini, Erica
    Mussini, Cristina
    Meschiari, Marianna
    ANTIBIOTICS-BASEL, 2022, 11 (08):
  • [36] New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
    Isler, Burcu
    Doi, Yohei
    Bonomo, Robert A.
    Paterson, David L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (01)
  • [37] Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality
    Hernandez-Torres, Alicia
    Garcia-Vazquez, Elisa
    Gomez, Joaquin
    Canteras, Manuel
    Ruiz, Joaquin
    Yaguee, Genoveva
    MEDICINA CLINICA, 2012, 138 (15): : 650 - 655
  • [38] Colistin, Hot Potato for the Therapy of Carbapenem-resistant Acinetobacter baumannii infections
    Park, Sang-Won
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (39)
  • [39] Carbapenem-resistant Acinetobacter baumannii in the Republic of Belarus
    Gorbich, Yury
    Karpov, Igor
    Edelstein, Mikhail
    Martinovich, Alexey
    Kretchikova, Olga
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (03) : 201 - 202
  • [40] Carbapenem-resistant Acinetobacter baumannii Bacteremia in Neonates
    Nakwan, Narongsak
    Chokephaibulkit, Kulkanya
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (02) : 197 - 197
12345